Alkermes plc sets May 31st Annual Meeting for director elections & pay votes
Ticker: ALKS · Form: DEF 14A · Filed: 2024-04-15T00:00:00.000Z
Sentiment: neutral
Topics: annual-meeting, corporate-governance, executive-compensation
Related Tickers: ALKS
TL;DR
Alkermes shareholders meeting May 31st to vote on directors & exec pay. Big decisions ahead.
AI Summary
Alkermes plc has scheduled its 2024 Annual General Meeting of Shareholders for May 31, 2024, in Dublin, Ireland. Key agenda items include the election of director nominees for a one-year term, a non-binding advisory vote on the compensation of named executive officers, and a non-binding advisory vote on the frequency of future executive compensation votes.
Why It Matters
Shareholders will vote on who leads the company and how executives are compensated, directly impacting corporate governance and potential future financial decisions.
Risk Assessment
Risk Level: low — This filing is a standard proxy statement for an annual general meeting, outlining routine corporate governance matters.
Key Players & Entities
- Alkermes plc (company) — Registrant and company holding the meeting
- May 31, 2024 (date) — Date of the Annual General Meeting
- Dublin 4, Ireland (location) — Location of the Annual General Meeting
FAQ
What is the date and time of Alkermes plc's 2024 Annual General Meeting?
The 2024 Annual General Meeting of Shareholders is scheduled for May 31, 2024, at 2:00 p.m., Irish Standard Time.
Where will the Alkermes plc 2024 Annual General Meeting be held?
The meeting will be held at the Company's offices at Connaught House, 1 Burlington Road, Dublin 4, Ireland, D04 C5Y6.
What is the primary purpose of the director elections at the meeting?
The primary purpose is to elect director nominees to serve on the Company's Board of Directors for a one-year term until the Company's 2025 annual general meeting of shareholders.
What is the nature of the vote on the compensation of named executive officers?
The vote on the compensation of the Company's named executive officers is a non-binding, advisory vote.
What is the third item on the agenda for the Annual General Meeting?
The third item is to approve, in a non-binding, advisory vote, the frequency of future advisory votes on the compensation of the Company's named executive officers.
Filing Stats: 4,516 words · 18 min read · ~15 pages · Grade level 15 · Accepted 2024-04-15 16:18:16
Key Financial Figures
- $1 b — ents. We achieved revenues in excess of $1 billion, primarily driven by our three pr
- $486 million — sumption of royalties and approximately $486 million in revenue in 2023, and settled favorab
Filing Documents
- alks-20240415.htm (DEF 14A) — 3953KB
- alks-alks_2024_def_14a.pdf (DEF 14A) — 4200KB
- img77518306_0.jpg (GRAPHIC) — 57KB
- img77518306_1.jpg (GRAPHIC) — 22KB
- img77518306_2.jpg (GRAPHIC) — 12KB
- img77518306_3.jpg (GRAPHIC) — 29KB
- img77518306_4.jpg (GRAPHIC) — 10KB
- img77518306_5.jpg (GRAPHIC) — 12KB
- img77518306_6.jpg (GRAPHIC) — 1KB
- img77518306_7.jpg (GRAPHIC) — 1KB
- img77518306_8.jpg (GRAPHIC) — 1KB
- img77518306_9.jpg (GRAPHIC) — 1KB
- img77518306_10.jpg (GRAPHIC) — 136KB
- img77518306_11.jpg (GRAPHIC) — 59KB
- img77518306_12.jpg (GRAPHIC) — 27KB
- img77518306_13.jpg (GRAPHIC) — 38KB
- img77518306_14.jpg (GRAPHIC) — 21KB
- img77518306_15.jpg (GRAPHIC) — 110KB
- img77518306_16.jpg (GRAPHIC) — 104KB
- img77518306_17.jpg (GRAPHIC) — 19KB
- img77518306_18.jpg (GRAPHIC) — 1KB
- img77518306_19.jpg (GRAPHIC) — 1KB
- img77518306_20.jpg (GRAPHIC) — 1KB
- img77518306_21.jpg (GRAPHIC) — 1KB
- img77518306_22.jpg (GRAPHIC) — 21KB
- img77518306_23.jpg (GRAPHIC) — 104KB
- img77518306_24.jpg (GRAPHIC) — 110KB
- img77518306_25.jpg (GRAPHIC) — 94KB
- img77518306_26.jpg (GRAPHIC) — 19KB
- img77518306_27.jpg (GRAPHIC) — 6KB
- img77518306_28.jpg (GRAPHIC) — 15KB
- img77518306_29.jpg (GRAPHIC) — 3KB
- img77518306_30.jpg (GRAPHIC) — 22KB
- img77518306_31.jpg (GRAPHIC) — 7KB
- img77518306_32.jpg (GRAPHIC) — 15KB
- img77518306_33.jpg (GRAPHIC) — 6KB
- img77518306_34.jpg (GRAPHIC) — 8KB
- img77518306_35.jpg (GRAPHIC) — 6KB
- img77518306_36.jpg (GRAPHIC) — 21KB
- img77518306_37.jpg (GRAPHIC) — 7KB
- img77518306_38.jpg (GRAPHIC) — 6KB
- img77518306_39.jpg (GRAPHIC) — 3KB
- img77518306_40.jpg (GRAPHIC) — 7KB
- img77518306_41.jpg (GRAPHIC) — 8KB
- img77518306_42.jpg (GRAPHIC) — 126KB
- img77518306_43.jpg (GRAPHIC) — 39KB
- img77518306_44.jpg (GRAPHIC) — 57KB
- img77518306_45.jpg (GRAPHIC) — 17KB
- img77518306_46.jpg (GRAPHIC) — 10KB
- img77518306_47.jpg (GRAPHIC) — 19KB
- img77518306_48.jpg (GRAPHIC) — 11KB
- img77518306_49.jpg (GRAPHIC) — 14KB
- img77518306_50.jpg (GRAPHIC) — 12KB
- img77518306_51.jpg (GRAPHIC) — 15KB
- img77518306_52.jpg (GRAPHIC) — 16KB
- img77518306_53.jpg (GRAPHIC) — 9KB
- img77518306_54.jpg (GRAPHIC) — 5KB
- img77518306_55.jpg (GRAPHIC) — 8KB
- img77518306_56.jpg (GRAPHIC) — 19KB
- img77518306_57.jpg (GRAPHIC) — 44KB
- img77518306_58.jpg (GRAPHIC) — 189KB
- img77518306_59.jpg (GRAPHIC) — 15KB
- img77518306_60.jpg (GRAPHIC) — 36KB
- img77518306_61.jpg (GRAPHIC) — 15KB
- img77518306_62.jpg (GRAPHIC) — 180KB
- img77518306_63.jpg (GRAPHIC) — 1KB
- img77518306_64.jpg (GRAPHIC) — 5KB
- img77518306_65.jpg (GRAPHIC) — 2KB
- img77518306_66.jpg (GRAPHIC) — 4KB
- img77518306_67.jpg (GRAPHIC) — 4KB
- img77518306_68.jpg (GRAPHIC) — 4KB
- img77518306_69.jpg (GRAPHIC) — 5KB
- img77518306_70.jpg (GRAPHIC) — 15KB
- img77518306_71.jpg (GRAPHIC) — 42KB
- img77518306_72.jpg (GRAPHIC) — 12KB
- img77518306_73.jpg (GRAPHIC) — 29KB
- img77518306_74.jpg (GRAPHIC) — 36KB
- img77518306_75.jpg (GRAPHIC) — 174KB
- img77518306_76.jpg (GRAPHIC) — 39KB
- img77518306_77.jpg (GRAPHIC) — 48KB
- img77518306_78.jpg (GRAPHIC) — 43KB
- img77518306_79.jpg (GRAPHIC) — 41KB
- img77518306_80.jpg (GRAPHIC) — 295KB
- img77518306_81.jpg (GRAPHIC) — 225KB
- 0000950170-24-044420.txt ( ) — 18147KB
- alks-20240415.xsd (EX-101.SCH) — 23KB
- alks-20240415_htm.xml (XML) — 238KB
EXECUTIVE COMPENSATION—COMPENSATION DISCUSSION AND ANALYSIS
EXECUTIVE COMPENSATION—COMPENSATION DISCUSSION AND ANALYSIS 82 ADDITIONAL COMPENSATION INFORMATION 108 COMPENSATION COMMITTEE REPORT 111
EXECUTIVE COMPENSATION TABLES
EXECUTIVE COMPENSATION TABLES 112 PAY VERSUS PERFORMANCE 124 PAY RATIO 127 CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS 128 EQUITY COMPENSATION PLAN INFORMATION 129 OTHER INFORMATION 130 APPENDIX A—ALKERMES PLC 2018 STOCK OPTION AND INCENTIVE PLAN, AS AMENDED A- 1 APPENDIX B—GAAP TO NON-GAAP RECONCILIATION / NON-GAAP FINANCIAL TARGETS B- 1 ALKERMES PLC 2024 Proxy Statement 1 Table of Contents Proxy Summary This proxy summary highlights information that is described in more detail elsewhere in this proxy statement. This summary does not contain all the information you should consider, and you should read the entire proxy statement carefully before voting. Your vote is very important. 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS Meeting Date and Time: May 31, 2024, 2:00 p.m., Irish Standard Time Place: Connaught House, 1 Burlington Road, Dublin 4, Ireland, D04 C5Y6 Record Date: March 18, 2024 COMPANY INFORMATION Ticker: ALKS Listing Exchange: Nasdaq Global Select Market Transfer Agent: Computershare Trust Company, N.A Corporate Website: www.alkermes.com Investor Relations Website: investor.alkermes.com Corporate Governance Documents: investor.alkermes.com/corporate-governance Purpose of this Proxy Statement The board of directors of Alkermes plc (the "Board") is soliciting proxies for use at the 2024 annual general meeting of shareholders of Alkermes plc (including any adjournments or postponements thereof, the "Annual Meeting"). This proxy statement contains important information for you to consider when deciding how to vote on matters to be brought before the Annual Meeting. Please read it carefully. This proxy statement is first being made available to our shareholders on or about April 15, 2024. This proxy statement is also available online at http://www.proxydocs.com/ALKS . The specific proposals to be considered and acted upon at the Annual Meeting are summarized below and